A biotech superstar with UNTHSC roots
By Jan Jarvis
Six years ago in an acceleration lab at UNT Health Science Center, the co-founders of ZS Pharma were developing a drug that they believed held great promise. But even with such lofty expectations, ZS Pharma co-founders Alvaro Guillem and Jeff Keyser may have underestimated their biotech startup’s potential.
Earlier this month British drug maker AstraZeneca agreed to acquire ZS Pharma for $2.7 billion in cash.
In the pharmaceutical world – where it typically takes a decade or more to move a drug from bench to bedside – ZS Pharma has moved at lightning speed. UNT Health Science Center helped make it all possible by providing offices, conference rooms and a lab where much of the work was done, Guillem said.
“During the early years it was critical to have the support of institutions like UNTHSC and the accelerator labs to be able to move the project forward,” Guillem said. “To this day, we continue to collaborate with labs and rely on their equipment and expertise to address various technical topics.”
From the start, ZS Pharma had all the making of a biotech superstar. Founded in 2008, it debuted on Wall Street as the first biotech IPO in Texas since 2000. Its drug, called ZS-9, has been on the fast track from the start.
Multiple clinical trials have shown the effectiveness of the drug, which is expected to hit the market in 2016. It treats hyperkalemia, a potentially life-threatening disease caused by excess potassium. About one in 200,000 people have the condition, which often affects people with chronic kidney disease and chronic heart failure.
Since 2006, UNT Health Science Center’s Office of Research Development and Commercialization and TECH Fort Worth, a non-profit technology incubator, have worked in partnership to bring new technologies to the market.
Firms get a boost from the UNTHSC Accelerator Lab Program along with the Executives-in-Residence, who act as mentors and offer advice from their years of experience in the pharmaceutical industry.
Taking research to the marketplace can be an arduous process. Playing a part in getting this drug on the path to patients has been rewarding for everyone involved , said Lawrence “Joe” Allred, Associate Vice President for Research and Innovation at UNTHSC.
“We can rightfully take pride in ZS Pharma’s success as a graduation of incubation in our Accelerator Labs,” he said.
By Cari Hyden Looking for a good book to read? Have you just finished a riveting volume that you’d like to share with others? UNTHSC just opened its second Little Free Library. It’s in the Lewis Library lobby, near the Java Lab. There you can feel free to pick up a book to read. Then next...Read more
May 20, 2019
By Jan Jarvis Halfway through his first year in medical school, Parker Murray fell apart. Homesick, depressed and overwhelmed, the Utah native collapsed on his bed one weekend. “I cried like two days straight,” he said. “I felt like I was drowning and struggled to pull myself toge...Read more
May 15, 2019
By Alex Branch Would a bicycle get you to work faster? Maybe you’ve pondered that question in your car during a slow, congested morning commute. Two UNT Health Science Center College of Pharmacy professors will answer the question — albeit quite unscientifically — Friday on For...Read more
May 15, 2019
By Alex Branch Gene and Helga Lukacsy will never forget the worry and sleepless nights after their son went missing in October 2016. Anthony Lukacsy, 46, faced his share of life struggles and was homeless. But he always periodically checked in with family, even if just to ask f...Read more
May 14, 2019